Intel Capital, the corporate venturing unit of US-listed chipmaker Intel, has continued to cut the value of its listed portfolio in the 12 months to end-June.

In a regulatory filing this month, Intel said it corporate venturing unit as well as the Middlefield Ventures portfolio held stakes in listed portfolio companies worth an aggregate $192.1m at the end of June. This was down from $388m in June 2011 even though the number of listed holdings increased due to portfolio company flotations over the past year.

The big reductions were in Intel’s holdings of Clearwire, which are now worth $31.8m down from $107.5m; cloud computing company VMWare’s $10m of stock down from $238m; US-based healthcare company Pacific Biosciences ($918,000 from $19.7m); Dutch-based semiconductor company ASM International ($6.85m from $10.8m); Harmonic (zero from $2.2m); and China-based technology services company HiSoft Technology (zero from $9.7m).

Nasdaq-listed HiSoft has just agreed to merge…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?